Literature DB >> 31840034

Genotyping of the OATP1B1 c. 521 T>C Polymorphism from the Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens: an Optimized Protocol.

Alexandra R Crowe1, Jonathan Miller1, Wei Yue1.   

Abstract

Organic anion transporting polypeptide (OATP) 1B1 is a liver-specific transport protein that plays an important role in hepatic drug disposition. It transports many drugs from the blood into the liver, including lipid-lowering statins. The c. 521 T>C polymorphism of OATP1B1 has reduced transport activity and is associated with statin-induced myopathy. Formalin-fixed paraffin-embedded (FFPE) liver tissues can be an enriched source for genotyping of this clinically significant OATP1B1 polymorphism in retrospective studies. The successfulness of genotyping using Sanger-sequencing of a PCR product from FFPE tissue relies on a successful PCR amplification using genomic DNA extracted from the FFPE tissues. Such PCR amplification is often limited by the quality of DNA extracted from the FFPE tissue. An optimized method for high-quality DNA extraction and efficient PCR amplification is highly needed in order to genotype polymorphisms such as the c. 521 T>C polymorphism using FFPE tissues. The current study established an optimized and reproducible method for a Sanger-sequencing-based genotyping method using FFPE human liver tissues that is applicable to even small FFPE tissues such as needle-core biopsy specimens.

Entities:  

Keywords:  Formalin-fixed paraffin-embedded tissue; Genotyping; Hepatic drug disposition; Membrane transport proteins; Organic anion transporting polypeptide (OATP)

Year:  2019        PMID: 31840034      PMCID: PMC6909936          DOI: 10.21769/BioProtoc.3343

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  13 in total

1.  NanoDrop microvolume quantitation of nucleic acids.

Authors:  Philippe Desjardins; Deborah Conklin
Journal:  J Vis Exp       Date:  2010-11-22       Impact factor: 1.355

2.  Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms.

Authors:  Takashi Nozawa; Hironobu Minami; Shigeki Sugiura; Akira Tsuji; Ikumi Tamai
Journal:  Drug Metab Dispos       Date:  2004-12-17       Impact factor: 3.922

3.  Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Nonsynonymous Single-Nucleotide Polymorphism.

Authors:  Alexandra Crowe; Wei Zheng; Jonathan Miller; Sonia Pahwa; Khondoker Alam; Kar-Ming Fung; Erin Rubin; Feng Yin; Kai Ding; Wei Yue
Journal:  Pharm Res       Date:  2019-05-15       Impact factor: 4.200

4.  A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.

Authors:  B Hsiang; Y Zhu; Z Wang; Y Wu; V Sasseville; W P Yang; T G Kirchgessner
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

5.  HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.

Authors:  Ruben C Hartkoorn; Wai San Kwan; Victoria Shallcross; Ammara Chaikan; Neill Liptrott; Deirdre Egan; Enrique Salcedo Sora; Chloë E James; Sara Gibbons; Pat G Bray; David J Back; Saye H Khoo; Andrew Owen
Journal:  Pharmacogenet Genomics       Date:  2010-02       Impact factor: 2.089

6.  Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.

Authors:  Steven G Simonson; Ali Raza; Paul D Martin; Patrick D Mitchell; John A Jarcho; Colin D A Brown; Amy S Windass; Dennis W Schneck
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

7.  Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.

Authors:  Bo Feng; Jinghai J Xu; Yi-An Bi; Rouchelle Mireles; Ralph Davidson; David B Duignan; Scott Campbell; Vsevolod E Kostrubsky; Margaret C Dunn; Arthur R Smith; Huifen F Wang
Journal:  Toxicol Sci       Date:  2009-02-17       Impact factor: 4.849

8.  Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors.

Authors:  Roos L Oostendorp; Evita van de Steeg; Cornelia M M van der Kruijssen; Jos H Beijnen; Kathryn E Kenworthy; Alfred H Schinkel; Jan H M Schellens
Journal:  Drug Metab Dispos       Date:  2009-01-12       Impact factor: 3.922

Review 9.  Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.

Authors:  Yoshihisa Shitara; Kazuya Maeda; Kazuaki Ikejiri; Kenta Yoshida; Toshiharu Horie; Yuichi Sugiyama
Journal:  Biopharm Drug Dispos       Date:  2013-01       Impact factor: 1.627

10.  Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors.

Authors:  Varun Khurana; Mukul Minocha; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Metabol Drug Interact       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.